1-7 of 7
Leslie S. Kean
Close
Sort by
Journal Articles

Real-world experience with low-dose IL-2 for children and young adults with refractory chronic graft-versus-host disease

Clinical Trials & Observations
Holly Wobma, Malika Kapadia, Haesook T. Kim, Francesca Alvarez-Calderon, Susanne H. C. Baumeister, Christine Duncan, Suzanne Forrest, Lev Gorfinkel, Jennifer Huang, Leslie E. Lehmann, Hojun Li, Marc Schwartz, John Koreth, Jerome Ritz, Leslie S. Kean, Jennifer S. Whangbo
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4647–4657.
https://doi.org/10.1182/bloodadvances.2023009729
Published: 2023
Includes: Supplemental data
Journal Articles

Abatacept for the prevention of GVHD in patients receiving mismatched unrelated transplants: a real-world analysis

Sharmila Raghunandan, Lev Gorfinkel, Michael Graiser, Brandi Bratrude, Yvonne Suessmuth, Scott Gillespie, Adrianna Lynn Westbrook, Kirsten M. Williams, Michelle L. Schoettler, Leslie S. Kean, John Horan, Amelia A. Langston, Muna Qayed, Benjamin Watkins
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4395–4399.
https://doi.org/10.1182/bloodadvances.2023010225
Published: 2023
Journal Articles

Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced-intensity conditioning HCT

Ashley V. Geerlinks, Brooks Scull, Christa Krupski, Ryan Fleischmann, Michael A. Pulsipher, Mary Eapen, James A. Connelly, Catherine M. Bollard, Sung-Yun Pai, Christine N. Duncan, Leslie S. Kean, K. Scott Baker, Lauri M. Burroughs, Jeffrey R. Andolina, Shalini Shenoy, Philip Roehrs, Rabi Hanna, Julie-An Talano, Kirk R. Schultz, Elizabeth O. Stenger, Howard Lin, Adi Zoref-Lorenz, Kenneth L. McClain, Michael B. Jordan, Tsz-Kwong Man, Carl E. Allen, Rebecca A. Marsh
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3725–3734.
https://doi.org/10.1182/bloodadvances.2022009478
Published: 2023
Includes: Supplemental data
Journal Articles

Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation

Clinical Trials & Observations
Muna Qayed, Benjamin Watkins, Scott Gillespie, Brandi Bratrude, Kayla Betz, Sung W. Choi, Jeffrey Davis, Christine Duncan, Roger Giller, Michael Grimley, Andrew C. Harris, David Jacobsohn, Nahal Lalefar, Maxim Norkin, Nosha Farhadfar, Michael A. Pulsipher, Shalini Shenoy, Aleksandra Petrovic, Kirk R. Schultz, Gregory A. Yanik, Edmund K. Waller, Amelia Langston, Leslie S. Kean, John T. Horan
Journal: Blood Advances
Blood Adv (2022) 6 (3): 746–749.
https://doi.org/10.1182/bloodadvances.2021005208
Published: 2022
Includes: Supplemental data
Journal Articles

Creating an international network for science and clinical progress: democratizing dissemination of advances in global hematology

Leslie S. Kean
Journal: Blood Advances
Blood Adv (2021) 5 (1): 275–276.
https://doi.org/10.1182/bloodadvances.2020004108
Published: 2021
Journal Articles

Risk factors for transplant-associated thrombotic microangiopathy and mortality in a pediatric cohort

Clinical Trials & Observations
Michelle Schoettler, Leslie E. Lehmann, Steven Margossian, Maia Lee, Leslie S. Kean, Pei-Chi Kao, Clement Ma, Christine N. Duncan
Journal: Blood Advances
Blood Adv (2020) 4 (11): 2536–2547.
https://doi.org/10.1182/bloodadvances.2019001242
Published: 2020
Includes: Supplemental data
Journal Articles

IL-2 enhances ex vivo–expanded regulatory T-cell persistence after adoptive transfer

Scott N. Furlan, Karnail Singh, Christina Lopez, Victor Tkachev, Daniel Joel Hunt, James Hibbard, Kayla M. Betz, Bruce R. Blazar, Cole Trapnell, Leslie S. Kean
Journal: Blood Advances
Blood Adv (2020) 4 (8): 1594–1605.
https://doi.org/10.1182/bloodadvances.2019001248
Published: 2020
Includes: Supplemental data